Changing diabetes in Bangladesh
Download case: Blueprint for change: Changing diabetes in Bangladesh (PDF)
Complex issues involving awareness, accessibility, affordability and availability are preventing millions of people who live with diabetes in least developed countries from receiving high-quality care. Appropriate partners should be involved in converging around these issues and barriers.
When each partner puts the patient at the centre of the mission, and when critical success factors are in place, the effect can be far greater than any one party can accomplish on its own. In Bangladesh, Novo Nordisk has been actively supporting healthcare system strengthening through physician education, infrastructure development and affordability improvements. The value to the Bangladeshi society is reflected in higher rates of diagnosis, treatment initiation and improved overall quality of diabetes care in the country. At the same time, Novo Nordisk has been able to increase sales volume significantly while enhancing company’s reputation and stakeholder support in Bangladesh in the past decade.
When each partner puts the patient at the centre of the mission, and when critical success factors are in place, the effect can be far greater than any one party can accomplish on its own. It creates a path to shared value.